{
 "companyname": "CYTORI THERAPEUTICS, INC.",
 "symbol": "CYTX",
 "description": "Surgical and Medical Instruments and Apparatus",
 "quarters": [
  {
   "cik": "0001095981",
   "companyname": "CYTORI THERAPEUTICS, INC.",
   "entityid": 85118,
   "primaryexchange": "Nasdaq Global Market",
   "primarysymbol": "CYTX",
   "siccode": "3841",
   "sicdescription": "Surgical and Medical Instruments and Apparatus",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "11/6/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "9/30/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 3,
   "dcn": "0001140361-15-040028",
   "currencycode": "USD",
   "crosscalculated": true,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": -1376000,
   "changeincurrentliabilities": -329000,
   "changeininventories": -740000,
   "dividendspaid": 0,
   "effectofexchangerateoncash": 14000,
   "capitalexpenditures": -47000,
   "cashfromfinancingactivities": 1319000,
   "cashfrominvestingactivities": -47000,
   "cashfromoperatingactivities": -6158000,
   "cfdepreciationamortization": 465000,
   "changeinaccountsreceivable": -413000,
   "investmentchangesnet": null,
   "netchangeincash": -4872000,
   "totaladjustments": -7686000,
   "ebit": 1997000,
   "costofrevenue": 502000,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": 0,
   "grossprofit": 1975000,
   "incomebeforetaxes": 1527000,
   "interestexpense": -669000,
   "netincome": 1527000,
   "netincomeapplicabletocommon": 1527000,
   "researchdevelopmentexpense": 4352000,
   "totalrevenue": 2477000,
   "sellinggeneraladministrativeexpenses": 2936000,
   "commonstock": 159000,
   "deferredcharges": null,
   "cashandcashequivalents": 18970000,
   "cashcashequivalentsandshortterminvestments": 18970000,
   "goodwill": 3922000,
   "intangibleassets": 9196000,
   "inventoriesnet": 4612000,
   "minorityinterest": null,
   "otherassets": 1214000,
   "othercurrentassets": 1314000,
   "othercurrentliabilities": 1725000,
   "otherequity": null,
   "otherliabilities": 12527000,
   "preferredstock": 0,
   "propertyplantequipmentnet": 1734000,
   "retainedearnings": -354255000,
   "totalassets": 42446000,
   "totalcurrentassets": 26030000,
   "totalcurrentliabilities": 9450000,
   "totalliabilities": 37446000,
   "totallongtermdebt": 14978000,
   "totalreceivablesnet": 1134000,
   "totalshorttermdebt": 1446000,
   "totalstockholdersequity": 5000000,
   "treasurystock": null
  },
  {
   "cik": "0001095981",
   "companyname": "CYTORI THERAPEUTICS, INC.",
   "entityid": 85118,
   "primaryexchange": "Nasdaq Global Market",
   "primarysymbol": "CYTX",
   "siccode": "3841",
   "sicdescription": "Surgical and Medical Instruments and Apparatus",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "8/10/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "6/30/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 2,
   "dcn": "0001140361-15-030777",
   "currencycode": "USD",
   "crosscalculated": true,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": 904000,
   "changeincurrentliabilities": 1081000,
   "changeininventories": 630000,
   "dividendspaid": -3000,
   "effectofexchangerateoncash": -29000,
   "capitalexpenditures": -310000,
   "cashfromfinancingactivities": 15753000,
   "cashfrominvestingactivities": -323000,
   "cashfromoperatingactivities": -4758000,
   "cfdepreciationamortization": 540000,
   "changeinaccountsreceivable": -2000,
   "investmentchangesnet": null,
   "netchangeincash": 10643000,
   "totaladjustments": -9207000,
   "ebit": 5792000,
   "costofrevenue": 1296000,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": -260000,
   "grossprofit": 2165000,
   "incomebeforetaxes": 4710000,
   "interestexpense": -936000,
   "netincome": 4450000,
   "netincomeapplicabletocommon": 4450000,
   "researchdevelopmentexpense": 6048000,
   "totalrevenue": 3461000,
   "sellinggeneraladministrativeexpenses": 3447000,
   "commonstock": 151000,
   "deferredcharges": null,
   "cashandcashequivalents": 23842000,
   "cashcashequivalentsandshortterminvestments": 23842000,
   "goodwill": 3922000,
   "intangibleassets": 9255000,
   "inventoriesnet": 4079000,
   "minorityinterest": null,
   "otherassets": 1480000,
   "othercurrentassets": 986000,
   "othercurrentliabilities": 2192000,
   "otherequity": null,
   "otherliabilities": 18187000,
   "preferredstock": 0,
   "propertyplantequipmentnet": 1860000,
   "retainedearnings": -355782000,
   "totalassets": 46524000,
   "totalcurrentassets": 29657000,
   "totalcurrentliabilities": 9221000,
   "totalliabilities": 44264000,
   "totallongtermdebt": 16184000,
   "totalreceivablesnet": 750000,
   "totalshorttermdebt": 26000,
   "totalstockholdersequity": 2260000,
   "treasurystock": null
  },
  {
   "cik": "0001095981",
   "companyname": "CYTORI THERAPEUTICS, INC.",
   "entityid": 85118,
   "primaryexchange": "Nasdaq Global Market",
   "primarysymbol": "CYTX",
   "siccode": "3841",
   "sicdescription": "Surgical and Medical Instruments and Apparatus",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "5/11/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "3/31/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 1,
   "dcn": "0001140361-15-018816",
   "currencycode": "USD",
   "crosscalculated": false,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": 125000,
   "changeincurrentliabilities": 159000,
   "changeininventories": 100000,
   "dividendspaid": -72000,
   "effectofexchangerateoncash": 15000,
   "capitalexpenditures": -187000,
   "cashfromfinancingactivities": 3779000,
   "cashfrominvestingactivities": -187000,
   "cashfromoperatingactivities": -5030000,
   "cfdepreciationamortization": 470000,
   "changeinaccountsreceivable": 546000,
   "investmentchangesnet": null,
   "netchangeincash": -1423000,
   "totaladjustments": 16928000,
   "ebit": -20997000,
   "costofrevenue": 598000,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": 1748000,
   "incomebeforetaxes": -21958000,
   "interestexpense": -1072000,
   "netincome": -21958000,
   "netincomeapplicabletocommon": -22619000,
   "researchdevelopmentexpense": 3963000,
   "totalrevenue": 2346000,
   "sellinggeneraladministrativeexpenses": 3338000,
   "commonstock": 114000,
   "deferredcharges": null,
   "cashandcashequivalents": 13199000,
   "cashcashequivalentsandshortterminvestments": 13199000,
   "goodwill": 3922000,
   "intangibleassets": 9350000,
   "inventoriesnet": 4614000,
   "minorityinterest": null,
   "otherassets": 1785000,
   "othercurrentassets": 1344000,
   "othercurrentliabilities": 3088000,
   "otherequity": null,
   "otherliabilities": 25237000,
   "preferredstock": 0,
   "propertyplantequipmentnet": 1778000,
   "retainedearnings": -360231000,
   "totalassets": 37046000,
   "totalcurrentassets": 19861000,
   "totalcurrentliabilities": 18702000,
   "totalliabilities": 60241000,
   "totallongtermdebt": 15677000,
   "totalreceivablesnet": 704000,
   "totalshorttermdebt": 10000000,
   "totalstockholdersequity": -23195000,
   "treasurystock": null
  }
 ]
}